Valuation Amplia Therapeutics Limited OTC Markets

Stocks

Delayed OTC Markets 23:24:21 22/09/2026 +04			5-day change	1st Jan Change
0.0917 ^USD	+9.90%		+12.31%	+16.22%

09-15	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
08-04	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2023	2025	2026	2027	2028	2029
Market Cap ¹	16.49	27.16	120.6	61.6	-	-
Change	-	-	343.99%	-48.91%	-	-
Enterprise Value (EV) ¹	16.49	27.16	92.72	43.7	38.2	44.2
Change	-	-	241.42%	-52.87%	-12.59%	15.71%
P/E	-2.64x	-3.27x	-14.3x	-5.22x	-17.1x	-10.9x
PBR	-	-	-	-	-	-
PEG	-	-	0.6x	-0.1x	0.2x	-0.2x
Capitalization / Revenue	-	-	-	-	6.48x	6.48x
EV / Revenue	-	-	-	-	4.02x	4.65x
EV / EBITDA	-	-	-11.2x	-3.8x	-9.55x	-7.37x
EV / EBIT	-	-	-11.1x	-3.77x	-9.32x	-7.25x
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0322	-0.0214	-0.0164	-0.023	-0.007	-0.011
Distribution rate	-	-	-	-	-	-
Net sales ¹	-	-	-	-	9.5	9.5
EBITDA ¹	-	-	-8.297	-11.5	-4	-6
EBIT ¹	-	-	-8.389	-11.6	-4.1	-6.1
Net income ¹	-6.242	-6.572	-7.707	-11.6	-4.1	-6.1
Net Debt ¹	-	-	-27.85	-17.9	-23.4	-17.4
Reference price ²	0.0850	0.0700	0.2350	0.1200	0.1200	0.1200
Nbr of stocks (in thousands)	194,006	387,953	513,072	513,312	-	-
Announcement Date	30/05/23	30/05/25	29/05/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
WUXI APPTEC CO., LTD.	21.8x	7.74x	15.55x	1.36%	74.27B
ARGENX SE	31.81x	9.18x	28.6x	0.04%	61.21B
WUXI BIOLOGICS (CAYMAN) INC.	31.83x	6.79x	17.62x	-.--%	27.55B
INSMED INCORPORATED	-73.75x	14.26x	-68.76x	-.--%	26.38B
BIONTECH SE	-15.46x	5.96x	-7.5x	-.--%	25.34B
GENMAB A/S	28.48x	5.36x	17.82x	-.--%	20.84B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1066.25x	37.33x	644.76x	-.--%	14.94B
PHARMAESSENTIA CORPORATION	43.75x	16.03x	32.53x	0.34%	15.17B
EXELIXIS, INC.	17.96x	5.35x	12.5x	-.--%	14.41B
Average	128.07x	12.00x	77.01x	0.19%	31.12B
Weighted average by Cap.	69.79x	10.14x	43.06x	0.39%